Novo Integrated Sciences, Inc. (NVOS)

NASDAQ: NVOS · IEX Real-Time Price · USD
-0.008 (-6.54%)
At close: Mar 27, 2023, 4:00 PM
-0.002 (-1.83%)
After-hours: Mar 27, 2023, 7:59 PM EDT

Company Description

Novo Integrated Sciences, Inc., together with its subsidiaries, provides multidisciplinary primary health care related products and services.

It operates through two segments, Healthcare Services, and Product Manufacturing and Development. The company offers physiotherapy, chiropractic care, manual/manipulative therapy, occupational therapy, eldercare, massage therapy, acupuncture and functional dry needling, chiropody, stroke and traumatic brain injury/neurological rehabilitation, kinesiology, vestibular therapy, concussion management and baseline testing, trauma sensitive yoga and meditation for concussion-acquired brain injury and occupational stress-PTSD, women's pelvic health program, sports medicine therapy, assistive devices, dietitian, holistic nutrition, fall prevention education, sports team conditioning program, and private personal training services.

It also engages in the assessment, diagnosis, treatment, pain management, rehabilitation, education, and prevention of various orthopedic, musculoskeletal, sports injury, and neurological conditions across various demographics, including pediatric, adult, and geriatric populations.

In addition, the company offers eldercare physiotherapy services, such as long-term care homes, retirement homes, community based home care physiotherapy, community based group exercise classes and fall prevention programs, and community-based outpatient clinics; and elderly occupational therapy services for retirement home and community, and long-term care sectors.

Further, it offers medical technology services, such as telemedicine and remote patient monitoring; and develops and distributes personalized health and wellness product solutions.

The company operates 16 owned clinics. The company was incorporated in 2000 and is based in Bellevue, Washington.

Novo Integrated Sciences, Inc. operates as a subsidiary of ALMC-ASAP Holdings, Inc.

Novo Integrated Sciences, Inc.
Novo Integrated Sciences logo
Country United States
Founded 2000
IPO Date Sep 22, 2017
Industry Medical Care Facilities
Sector Healthcare
Employees 73
CEO Mr. Robert Mattacchione

Contact Details

11120 Ne 2nd Street, Suite 100
Bellevue, Washington 98004
United States
Phone (206) 617-9797

Stock Details

Ticker Symbol NVOS
Exchange NASDAQ
Fiscal Year September - August
Reporting Currency USD
CIK Code 0001138978
CUSIP Number 67011T201
ISIN Number US67011T2015
Employer ID 59-3691650
SIC Code 3510

Key Executives

Name Position
Robert Mattacchione Chairman and Chief Executive Officer
Christopher Mehlin David Chief Operating Officer, President and Director
James Zsebok Principal Financial Officer
Dr. Indrajit Sinha Ph.D. Chief Science Officer
David Brien BSc.PT, BSc.Bio Senior Vice President of Clinical Operations - Eastern Ontario
Dr. Joseph M. Chalil FACHE, M.B.A., M.D. Chief Medical Officer and Chairman of Medical Advisory Board
Emily Mattacchione Treasurer

Latest SEC Filings

Date Type Title
Mar 27, 2023 8-K Current Report
Mar 24, 2023 8-K Current Report
Mar 1, 2023 8-K Current Report
Feb 14, 2023 8-K Current Report
Feb 10, 2023 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Jan 30, 2023 8-K Current Report
Jan 26, 2023 8-K Current Report
Jan 17, 2023 NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB
Jan 17, 2023 8-K Current Report
Jan 6, 2023 8-K Current Report